Stronger Neo-Minophagen C

DRUG2 trials

Sponsors

Division of Gstroenterological Mdicine, Kagoshima University Hospital, Chimei Medical Center

Conditions

Hepatocellular Carcinomanonalcoholic fatty liver disease

Phase 4

SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy

CompletedNCT04015245

Chimei Medical CenterHepatocellular Carcinoma

Start: 2018-04-12End: 2019-05-28Updated: 2019-07-10

Unknown Phase

Study for the effect of Stronger Neo-Minophagen C (SNMC) for nonalcoholic fatty liver disease (NAFLD)-multicenter clinical trial-

Active, not recruitingJPRN-UMIN000012336

Division of Gstroenterological Mdicine, Kagoshima University Hospitalnonalcoholic fatty liver disease

Start: 2013-11-25Target: 20Updated: 2026-06-29